Literature DB >> 32124989

Mitochondrial Sirtuins in Skin and Skin Cancers.

Shengqin Su1, Mary Ndiaye1, Chandra K Singh1, Nihal Ahmad1,2.   

Abstract

Mammalian sirtuins (SIRTs 1-7) are a family of NAD+-dependent deacetylases with distinct subcellular localization and biological functions that regulate various important cellular processes. Among these, SIRTs -3, -4 and -5 are located in the mitochondria and have been implicated in caloric restriction, oxidative stress, aging and various human diseases. Emerging evidence has found dysregulation of mitochondrial sirtuins in multiple dermatological conditions, including responses to ultraviolet radiation (UVR), suggesting their importance in maintaining skin health. In this review, we discuss the roles and implications of mitochondrial sirtuins in cutaneous cellular processes, and their emerging potential as a target for the management of skin diseases, including skin cancer. Among mitochondrial sirtuins, SIRT3 is the most studied and linked to multiple skin conditions and diseases (keratinocyte differentiation, wound healing, chronological aging, UVR and ozone response, systemic sclerosis, melanoma, basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)). SIRT4 has been connected to keratinocyte differentiation, chronological aging, UVR response, alopecia, BCC and SCC. Further, SIRT5 has been associated with keratinocyte differentiation, melanoma, BCC and SCC. Overall, while there is compelling evidence for the involvement of mitochondrial sirtuins in skin, additional detailed studies are needed to understand their exact roles in skin and skin cancers.
© 2020 American Society for Photobiology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32124989      PMCID: PMC7483225          DOI: 10.1111/php.13254

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  92 in total

Review 1.  Impact of BRAF mutation status in the prognosis of cutaneous melanoma: an area of ongoing research.

Authors:  Parisha Bhatia; Paul Friedlander; Elmageed A Zakaria; Emad Kandil
Journal:  Ann Transl Med       Date:  2015-02

Review 2.  Basal cell carcinoma: what's new under the sun.

Authors:  Clio Dessinioti; Christina Antoniou; Andreas Katsambas; Alexander J Stratigos
Journal:  Photochem Photobiol       Date:  2010 May-Jun       Impact factor: 3.421

3.  Gene expression changes in melanoma metastases in response to high-dose chemotherapy during isolated limb perfusion.

Authors:  Jasper Wouters; Marguerite Stas; Olivier Govaere; Kathleen Van den Eynde; Hugo Vankelecom; Joost J van den Oord
Journal:  Pigment Cell Melanoma Res       Date:  2012-05-03       Impact factor: 4.693

Review 4.  Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.

Authors:  E Archier; S Devaux; E Castela; A Gallini; F Aubin; M Le Maître; S Aractingi; H Bachelez; B Cribier; P Joly; D Jullien; L Misery; C Paul; J-P Ortonne; M-A Richard
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-05       Impact factor: 6.166

Review 5.  The epidemiology of skin cancer.

Authors:  Thomas L Diepgen; V Mahler
Journal:  Br J Dermatol       Date:  2002-04       Impact factor: 9.302

Review 6.  Mitochondrial Sirtuins and Molecular Mechanisms of Aging.

Authors:  Robert A H van de Ven; Daniel Santos; Marcia C Haigis
Journal:  Trends Mol Med       Date:  2017-03-10       Impact factor: 11.951

Review 7.  Sirtuins: critical regulators at the crossroads between cancer and aging.

Authors:  L R Saunders; E Verdin
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

8.  A nitric oxide-dependent cross-talk between class I and III histone deacetylases accelerates skin repair.

Authors:  Francesco Spallotta; Chiara Cencioni; Stefania Straino; Simona Nanni; Jessica Rosati; Simona Artuso; Isabella Manni; Claudia Colussi; Giulia Piaggio; Fabio Martelli; Sergio Valente; Antonello Mai; Maurizio C Capogrossi; Antonella Farsetti; Carlo Gaetano
Journal:  J Biol Chem       Date:  2013-03-05       Impact factor: 5.157

9.  Lysine glutarylation is a protein posttranslational modification regulated by SIRT5.

Authors:  Minjia Tan; Chao Peng; Kristin A Anderson; Peter Chhoy; Zhongyu Xie; Lunzhi Dai; Jeongsoon Park; Yue Chen; He Huang; Yi Zhang; Jennifer Ro; Gregory R Wagner; Michelle F Green; Andreas S Madsen; Jessica Schmiesing; Brett S Peterson; Guofeng Xu; Olga R Ilkayeva; Michael J Muehlbauer; Thomas Braulke; Chris Mühlhausen; Donald S Backos; Christian A Olsen; Peter J McGuire; Scott D Pletcher; David B Lombard; Matthew D Hirschey; Yingming Zhao
Journal:  Cell Metab       Date:  2014-04-01       Impact factor: 27.287

10.  MicroRNA-15b regulates mitochondrial ROS production and the senescence-associated secretory phenotype through sirtuin 4/SIRT4.

Authors:  Alexander Lang; Susanne Grether-Beck; Madhurendra Singh; Fabian Kuck; Sascha Jakob; Andreas Kefalas; Simone Altinoluk-Hambüchen; Nina Graffmann; Maren Schneider; Antje Lindecke; Heidi Brenden; Ingo Felsner; Hakima Ezzahoini; Alessandra Marini; Sandra Weinhold; Andrea Vierkötter; Julia Tigges; Stephan Schmidt; Kai Stühler; Karl Köhrer; Markus Uhrberg; Judith Haendeler; Jean Krutmann; Roland P Piekorz
Journal:  Aging (Albany NY)       Date:  2016-03       Impact factor: 5.682

View more
  3 in total

1.  Antimelanoma Effects of Concomitant Inhibition of SIRT1 and SIRT3 in BrafV600E/PtenNULL Mice.

Authors:  Gagan Chhabra; Chandra K Singh; Glorimar Guzmán-Pérez; Mary A Ndiaye; Kenneth A Iczkowski; Nihal Ahmad
Journal:  J Invest Dermatol       Date:  2021-09-29       Impact factor: 7.590

2.  Genetic Manipulation of Sirtuin 3 Causes Alterations of Key Metabolic Regulators in Melanoma.

Authors:  Chandra K Singh; Jasmine George; Gagan Chhabra; Minakshi Nihal; Hao Chang; Nihal Ahmad
Journal:  Front Oncol       Date:  2021-04-16       Impact factor: 6.244

3.  Combined Inhibition of Specific Sirtuins as a Potential Strategy to Inhibit Melanoma Growth.

Authors:  Chandra K Singh; Jennifer E Panackal; Sarah Siddiqui; Nihal Ahmad; Minakshi Nihal
Journal:  Front Oncol       Date:  2020-10-16       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.